Table 4.
Effect of 30 ligands on MC1R content (X ± SD, n = 6).
| Number | Ligands | MC1R (ng/L) | Inhibition (%) |
|---|---|---|---|
| Control | 4.389 ± 0.022 | 0 | |
| 1 | Licochalcone A | 2.590 ± 0.006 | 40.99 |
| 2 | Salvianolic acid A | 2.652 ± 0.006 | 39.58 |
| 3 | Linolenic acid | 2.679 ± 0.018 | 38.97 |
| 4 | Isochlorogenic acid A | 2.703 ± 0.025 | 38.44 |
| 5 | Melitose | 2.892 ± 0.025 | 34.13 |
| 6 | Isorhamnetin-3-O-neohespeidoside | 2.924 ± 0.025 | 33.39 |
| 7 | Isochlorogenic acid C | 3.178 ± 0.019 | 27.60 |
| 8 | Platycodin D | 3.187 ± 0.018 | 27.40 |
| 9 | Palmitoyl tripeptide-1 | 3.238 ± 0.022 | 26.25 |
| 10 | Ginsenoside Rg3 | 3.285 ± 0.006 | 25.18 |
| 11 | Ginsenoside Rb2 | 3.351 ± 0.007 | 23.43 |
| 12 | Matrixyl | 3.409 ± 0.003 | 22.35 |
| 13 | Aucubin | 3.418 ± 0.029 | 22.15 |
| 14 | Neohesperidin | 3.441 ± 0.018 | 21.61 |
| 15 | Argireline | 3.471 ± 0.005 | 20.93 |
| 16 | Nonapeptide-1 | 3.569 ± 0.029 | 18.71 |
| 17 | Asiaticoside | 3.592 ± 0.011 | 18.17 |
| 18 | Isoorientin | 3.666 ± 0.030 | 16.49 |
| 19 | Notoginsenoside R1 | 3.719 ± 0.006 | 15.28 |
| 20 | β-Sitosterol | 3.746 ± 0.020 | 14.67 |
| 21 | Isoliquiritin | 3.758 ± 0.011 | 14.41 |
| 22 | Ononin | 3.902 ± 0.018 | 11.11 |
| 23 | Procyanidin | 3.911 ± 0.024 | 10.91 |
| 24 | Palmitoyl tetrapeptide-7 | 3.920 ± 0.011 | 10.70 |
| 25 | Aloin | 3.923 ± 0.040 | 10.64 |
| 26 | (-)-Epigallocatechin gallate (EGCG) | 3.926 ± 0.025 | 10.57 |
| 27 | Bisdemethoxycurcumin | 4.033 ± 0.093 | 8.14 |
| 28 | Tannic acid | 4.133 ± 0.018 | 5.86 |
| 29 | Geniposide | 4.287 ± 0.028 | 2.36 |
| 30 | α-MSH | 4.582 ± 0.015 | -4.38 |
Compared with the control group, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Compared with arbutin, #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001.